Delayed diagnosis of congenital factor IX deficiency (Christmas disease) in a girl with Turner's Syndrome

2006 ◽  
Vol 28 (5) ◽  
pp. 355-356 ◽  
Author(s):  
G. KELSEY ◽  
P. MONAGLE ◽  
C. BARNES
Blood ◽  
1970 ◽  
Vol 36 (2) ◽  
pp. 169-179 ◽  
Author(s):  
THOMAS C. BITHELL ◽  
ALEJANDRO PIZARRO ◽  
WILLIAM D. MACDIARMID

Abstract The case of an 11-year-old girl with a severe bleeding diathesis, a factor IX level of 4 per cent, and 45, X Turner’s syndrome is described. Family studies revealed severe factor IX deficiency in 4 male relatives and mild deficiencies in 4 heterozygous female carriers. The Bm or B+ variant of this disorder was demonstrated in all affected members of the kindred.


Blood ◽  
1996 ◽  
Vol 87 (10) ◽  
pp. 4187-4196 ◽  
Author(s):  
GJ Miller ◽  
JC Martin ◽  
KA Mitropoulos ◽  
MP Esnouf ◽  
JA Cooper ◽  
...  

Factor VII activity (FVIIc), a risk marker for coronary heart disease, is increased during postprandial lipemia. Factor VII activation accompanies lipolysis of triglyceride-rich lipoproteins, but the nature of this association and whether it is causal remain uncertain. To explore this issue, four patients with homozygous factor XII deficiency, four with complete factor XI deficiency, six with factor IX deficiency, and their respective age- and sex-matched controls were given two isocaloric dietary regimens, one providing on average 136 g fat and the other 19 g fat. Blood was taken before breakfast, immediately before lunch at 195 minutes, and at completion of the study at 390 minutes. All samples for each subject and matched control were assayed as one batch for FVIIc, activated factor VII, and factor VII antigen (FVIIag). Activation of factor VII was observed with the high- fat regimen but not with the low-fat regimen in all controls, factor XII-deficient patients, and factor XI-deficient patients. No factor VII activation was observed during either regimen in factor IX-deficient patients, but a normal postprandial responsiveness of factor VII to dietary fat was restored in one patient who replicated the study after factor IX therapy. Plasma FVIIag was not altered postprandially in either regimen in any group of patients or controls. Factor IX apparently plays an obligatory role in the postprandial activation of factor VII, although the mechanism remains to be determined.


Author(s):  
A. González-Angulo ◽  
S. Armendares-Sagrera ◽  
I. Ruíz de Chávez ◽  
H. Marquez-Monter ◽  
R. Aznar

It is a well documented fact that endometrial hyperplasia and adenocarcinoma may develop in women with Turner's syndrome who had received unopposed estrogen treatment (1), as well as in normal women under contraceptive medication with the sequential regime (2). The purpose of the present study was to characterize the possible changes in surface and glandular epithelium in these women who were treated with a sequential regime for a period of between three and eight years. The aim was to find organelle modifications which may lead to the understanding of the biology of an endometrium under exogenous hormone stimulation. Light microscopy examination of endometrial biopsies of nine patients disclosed a proliferative pattern; in two of these, there was focal hyperplasia. With the scanning electron microscope the surface epithelium in all biopsies showed secretory cells with microvilli alternating with non secretory ciliated cells. Regardless of the day of the cycle all biopsies disclosed a large number of secretory cells rich in microvilli (fig.l) with long and slender projections some of which were branching (fig. 2).


1961 ◽  
Vol 05 (01) ◽  
pp. 093-096 ◽  
Author(s):  
F Nour-Eldin

SummaryThe clinical and laboratory findings in a case of Christmas factor deficiency associated with vascular abnormality are reported.The relation of this syndrome to Christmas disease and related conditions is discussed.


1974 ◽  
Vol 77 (1_Suppl) ◽  
pp. S48 ◽  
Author(s):  
F. Majewski ◽  
J. R. Bierich ◽  
M. Barz ◽  
W. F. Haberlandt ◽  
M. Stoeckenius

1986 ◽  
Vol 113 (4_Suppl) ◽  
pp. S157-S163 ◽  
Author(s):  
K.W. KASTRUP ◽  
_ _

Abstract Early therapy with a low dose of estrogen (estradiol-17β) was given to 33 girls with Turner's syndrome (T.s.) for a period of 4 years. The dose (0.25-2 mg/day) was adjusted every 3 months to maintain plasma estradiol in the normal concentration range for bone age. Growth velocity was compared with that of untreated girls with T.s. All girls were above age 10 years. Bone age was below 10 years in 11 girls (group I) and above 10 years in 22 girls (group II). Growth velocity in the first year of treatment in group I 7.5 ± 1.3 cm (SD) with mean SD score (SDS) of +4.3 and in group II 4.9 ± 1.3 with mean SDS of +3.5. Growth velocity decreased in the following years to 1.6 ± 1.0 cm, SDS -1.44 in group I and 0.9 ± 0.6cm, SDS -2.34 in group II during the fourth year. Withdrawal bleeding occurred in 16 girls of group II after the mean of 23 (range 15-33) months and in 3 girls of group I after 15 to 51 months of treatment. The treatment did not cause an inappropriate acceleration of pubertal development. Breast development appeared in most girls by 3 months of treatment. Pubic hair appeared by 12 months of treatment in group I; it was present in most girls in group II at start of treatment. Final height is known for 12 girls of group II; it was 144.2 ± 4.5 cm. The final height as predicted at the start of therapy was 142.2 ± 5.3 cm. Bone age advanced in the first year of treatment by 2 years. Early treatment with small doses of estrogens induces a growth spurt and normalizes the events of puberty. This will presumably decrease the psychological risks associated with abnormally delayed development.


Sign in / Sign up

Export Citation Format

Share Document